Skip to content
Riskpilot
← Tilbage til søgning
Log ind
Få fuld adgang
Cytoki Pharma ApS
APS
In liquidation
Reklamebeskyttelse
CVR 40594132
Vandtårnsvej 77, 2860
Søborg
Research and experimental development on natural sciences and engineering
· NACE 7210
Est. 2019 · 7 years old
3 employees
Overvåg
Share
Denmark
/
Companies
/
Research and experimental development on natural sciences and engineering
/
Cytoki Pharma ApS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Gross profit
DKK millions
0M
-9M
-18M
-28M
-37M
-32M
2021
-99M
2022
-62M
2023
-39M
2024
-42M
2025
EBITDA
DKK millions
0M
-33M
-67M
-100M
-134M
-37M
2021
-107M
-189%
2022
-70M
+35%
2023
-46M
+34%
2024
-49M
-7%
2025
Income statement
DKK thousands
Item
2021
2022
2023
2024
2025
Gross profit
-31.975
-98.764
-61.548
-39.133
-42.199
Staff expenses
-4.987
-8.079
-8.546
-7.178
-7.262
EBITDA
-36.962
-106.843
-70.094
-46.310
-49.461
Depreciation & amort.
-0
-0
-0
-0
-0
EBIT
-36.962
-106.843
-70.094
-46.310
-49.461
Net financials
1.413
2.949
75
1.549
161
Profit before tax
-35.549
-103.894
-70.019
-44.762
-49.300
Tax
-5.796
-5.500
-5.500
-5.500
-5.500
Net profit
-29.753
-98.394
-64.519
-39.262
-43.800
Balance sheet
DKK thousands
Item
2021
2022
2023
2024
2025
Total assets
116.214
68.865
73.927
62.886
17.963
Equity
106.806
51.217
66.697
57.274
13.474
Long-term debt
0
0
0
0
0
Short-term debt
9.408
17.648
7.230
5.612
4.489
Total debt
9.408
17.648
7.230
5.612
4.489
Financial ratios
5-year trend
EBITDA-margin (af bruttofortjeneste)
-4946117300.0%
This company
2021
2025
Soliditetsgrad
75.0%
This company
38.2%
Market median
+96% vs market
2021
2025
Egenkapitalforrentning
-325.1%
This company
18.4%
Market median
-1867% vs market
2021
2025
Nettoresultatgrad (af bruttofortjeneste)
-4380000700.0%
This company
2021
2025
Aktivomsætning (af bruttofortjeneste)
-2.35×
This company
2021
2025
Gæld/egenkapital
0.33×
This company
0.62×
Market median
+47% vs market
2021
2025
Annual reports & filings
Annual report 2025
Filed via CVR / Virk · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
View
PDF
More on Cytoki Pharma ApS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
